Rocket Pharmaceuticals, Inc. Common Stock (NASDAQ: RCKT) last traded at $2.48, down 3.13% on the session. The quote above updates while this page is open; the figures below are drawn from Rocket Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Rocket Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker RCKT. Its market capitalisation is $272.24 million.
Valuation measures for Rocket Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $272.24M |
|---|---|
| Enterprise value | $102.00M |
| Price / book | 0.74 |
| Beta | 1.73 |
Trailing-twelve-month figures tagged in Rocket Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$17.25M |
|---|
| EPS (TTM) | -$0.170 |
|---|
| Return on equity | -4.68% |
|---|
| Cash | $224.51M |
|---|
Range and volume for RCKT over the past 52 weeks.
| 52-week high | $5.45 |
|---|---|
| 52-week low | $2.42 |
| Volume | 2.30M |
| Average volume | 1.70M |
| Previous close | $2.56 |
Invest a chosen dollar amount in Rocket Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell RCKT.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.